About 4-methyl-N-[3-(2H-tetrazol-5-ylmethyl)-1,3-benzothiazol-2-ylidene]benzamide
4-methyl-N-[3-(2H-tetrazol-5-ylmethyl)-1,3-benzothiazol-2-ylidene]benzamide (PubChem CID 142713341) has the molecular formula C17H14N6OS
and a molecular weight of 350.41 g/mol. Its IUPAC name is 4-methyl-N-[3-(2H-tetrazol-5-ylmethyl)-1,3-benzothiazol-2-ylidene]benzamide.
Analyze 4-methyl-N-[3-(2H-tetrazol-5-ylmethyl)-1,3-benzothiazol-2-ylidene]benzamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 4-methyl-N-[3-(2H-tetrazol-5-ylmethyl)-1,3-benzothiazol-2-ylidene]benzamide?
The IUPAC name of 4-methyl-N-[3-(2H-tetrazol-5-ylmethyl)-1,3-benzothiazol-2-ylidene]benzamide (CID 142713341) is 4-methyl-N-[3-(2H-tetrazol-5-ylmethyl)-1,3-benzothiazol-2-ylidene]benzamide.
What is the SMILES notation for 4-methyl-N-[3-(2H-tetrazol-5-ylmethyl)-1,3-benzothiazol-2-ylidene]benzamide?
The canonical SMILES for 4-methyl-N-[3-(2H-tetrazol-5-ylmethyl)-1,3-benzothiazol-2-ylidene]benzamide is Cc1ccc(C(=O)/N=c2\sc3ccccc3n2Cc2nn[nH]n2)cc1.
What is the InChIKey of 4-methyl-N-[3-(2H-tetrazol-5-ylmethyl)-1,3-benzothiazol-2-ylidene]benzamide?
The InChIKey is MOWUWLPJSMMJGZ-ZCXUNETKSA-N. The full InChI is InChI=1S/C17H14N6OS/c1-11-6-8-12(9-7-11)16(24)18-17-23(10-15-19-21-22-20-15)13-4-2-3-5-14(13)25-17/h2-9H,10H2,1H3,(H,19,20,21,22)/b18-17-.
What are the key properties of 4-methyl-N-[3-(2H-tetrazol-5-ylmethyl)-1,3-benzothiazol-2-ylidene]benzamide?
4-methyl-N-[3-(2H-tetrazol-5-ylmethyl)-1,3-benzothiazol-2-ylidene]benzamide has a molecular weight of 350.41 g/mol, XLogP of 2.31, 3 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 4-methyl-N-[3-(2H-tetrazol-5-ylmethyl)-1,3-benzothiazol-2-ylidene]benzamide is sourced from PubChem (CID 142713341), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).